A LIMS manages samples and results. An ELN records experiments and the reasoning behind them. That is the core difference between them: a Laboratory Information Management System answers "where is this sample and what happened to it", and an Electronic Lab Notebook answers "what did this scientist do and what did they find".
QC labs in GMP manufacturing usually need a LIMS first. R&D labs usually need an ELN first. Many pharma and biotech companies end up with both, joined by an interface that has to be validated like any other part of the system. This guide covers what each one does, the functional differences, what compliance asks of each in a QC lab, where a laboratory execution system (LES) fits, and how to sequence the purchase.
What a LIMS does
A LIMS is a sample-centric operational system. It tracks each sample from receipt or creation through every test to a result and a disposition decision. It knows where the sample is, which tests were requested, which instrument ran it, what the result was and whether that result meets specification.
Around that core it manages work queues, instrument interfaces, reagents and reference standards, stability studies and chain of custody. In a GxP lab it also holds the audit trail and review evidence for each result. Common LIMS in regulated life sciences include LabWare, LabVantage, STARLIMS, SampleManager and Benchling LIMS. See LIMS validation for validation guidance specific to LIMS deployments.
What an ELN does
An ELN is an experiment-centric record. It replaces the paper notebook: how an experiment was designed, what was done, what was observed and what was concluded. Scientists write up methods, record data next to the reasoning behind it, attach files and images, and link related experiments across a project.
The content is semi-structured: free text, protocol steps, tables and attachments rather than fixed forms. Common ELNs include Benchling, Dotmatics, LabArchives, Signals Notebook (Revvity) and IDBS E-WorkBook.
LIMS vs ELN functionality: the differences that matter
The two systems differ in the unit they are built around. A LIMS is built around the sample and its result. An ELN is built around the experiment and its write-up. Most of the functional differences follow from that.
- Unit of record: LIMS, the sample, test and result. ELN, the experiment and its narrative.
- Structure: LIMS uses fixed workflows and status changes (received, in test, reviewed, released). ELN uses flexible templates that scientists adapt.
- Specifications: LIMS compares each result with its specification and flags failures. An ELN usually records results without enforcing limits.
- Instrument data: LIMS connects to instruments and chromatography data systems as a core function. Many ELNs rely on file import or connectors.
- Protocol authoring: ELN native. In a LIMS, the method is reference content attached to a test, not a working space.
- Inventory and sample tracking: LIMS native. ELNs often add it as a module, usually lighter.
- Review and release: LIMS routes results through review and approval before release. ELNs offer signing and witnessing of entries.
Vendors on both sides now add the other side's features, so the line looks blurred in demos. Most products are still clearly stronger at one job. Ask each vendor to show your own workflow end to end, not a feature list.
LIMS vs ELN in a QC laboratory: what compliance asks for
In a GMP QC lab, the question is not which tool is nicer to use but which one can hold a complete laboratory record. For US drug manufacturers, 21 CFR 211.194 lists what laboratory records must include:
- a description of the sample, its source, quantity, lot and dates;
- the method used, and the weight or measure of sample for each test;
- all data from each test, including graphs, charts and spectra from instruments;
- all calculations, with units and conversion factors;
- the results and how they compare with specifications;
- who performed each test and when, and a second person's review for accuracy, completeness and compliance.
A LIMS is designed around most of that list: sample identity, results against specification, and the second-person review. The raw instrument data usually stays in the instrument software or chromatography data system, so the record is complete only if the link between the two holds. An ELN alone rarely covers specification checks and release.
Whatever the mix, the computer controls apply to every system that holds part of the record. 21 CFR 211.68(b) requires that only authorised people change records and that input and output are checked for accuracy. EU GMP Annex 11 asks for built-in checks when systems exchange data (clause 5), a second check on critical data entered by hand (clause 6), and audit trails that are reviewed regularly (clause 9). In the US, electronic records and signatures kept to meet FDA requirements also fall under 21 CFR Part 11, in either system.
Where a laboratory execution system (LES) fits
A laboratory execution system guides an analyst through a method step by step and captures each entry as it happens: weights, instrument readings, reagent lots, timings. It sits between the two. An ELN is flexible and narrative. A LIMS holds the sample and the result. An LES enforces how the test itself is carried out.
QC labs use an LES to replace paper worksheets for routine methods. Some LIMS vendors offer it as a module; others sell it on its own and integrate it with the LIMS. Either way, the LES holds part of the 211.194 record (method steps, weights, calculations), so it is validated as a GxP system and its interface to the LIMS is tested like any other.
Integrating and validating LIMS, ELN and instrument software
When a lab has both, results move from instruments to the LIMS and context moves between the LIMS and the ELN. Each handoff is a place where data can be lost, duplicated or changed. Annex 11 clause 5 is the reason the interface needs its own built-in checks, and its own tests during validation.
Treat the interface as a validated component in its own right, configured or custom depending on how it is built. Test that records arrive complete, keep their attribution and are not altered. We cover the options in ELN and LIMS integration for mid-size pharma, and the testing in validating an ELN-LIMS integration under GAMP 5.
LIMS and ELN are both GxP computerised systems, and most teams validate them following ISPE GAMP 5 Second Edition with risk-based testing. The emphasis differs. LIMS validation is heavier on workflow: instrument interfaces, result calculations, specification checks, status changes and chain of custody. ELN validation is heavier on record controls: audit trail completeness, versioning, access control and electronic signatures. In both, check data integrity (ALCOA+) at the boundaries between systems, not only inside each one.
Cybroscape GxP Copilot drafts the validation package for systems like these from one intake: requirements, risk assessment, test cases and a live traceability matrix, with test depth set by each requirement's risk. Qualified people review and sign every deliverable.
Which to buy first
- QC labs in GMP manufacturing: LIMS first. Sample workflow, specification checks and instrument interfaces are the operational core. Consider an LES for routine methods, and an ELN later for method development.
- R&D and discovery labs: ELN first. Scientists need experiment records before they need workflow management. A LIMS follows when sample volumes and tracking needs grow.
- Analytical labs serving several programmes: Both, integrated. The LIMS runs sample operations; the ELN holds method development and the reasoning behind it.
- Clinical trial supply labs: LIMS first. Chain of custody, stability samples and specification enforcement need a purpose-built LIMS, not an ELN's sample module.
The decision in one sentence: if your main question is where is this sample and what happened to it, buy a LIMS. If it is what did this scientist do and what did they learn, buy an ELN. If you need both answers, as many pharma and biotech labs eventually do, plan for both with a validated interface between them. If you are validating either, book a demo to see how GxP Copilot drafts the package.
Where to go next
Explore GxP Copilot for AI-native validation, TraceDraft for source-traceable clinical documentation, or book a demo to see either on your own data.